You are here

RNAi

Alnylam Starts Rolling NDA Submission for RNAi Candidate

Yahoo/Zacks.com

Fri, 11/17/17 - 11:15 am

hereditary ATTR amyloidosis

Alnylam outshines Ionis with RNAi drug

BioPharma Dive

Sat, 11/4/17 - 08:40 am

Ionis Pharmaceuticals

Dicerna and Boehringer partner on RNAi treatment for NASH

Endpoints

Thu, 11/2/17 - 11:14 am

Boehringer Ingelheim

A drug 15 years in the making: Alnylam's quest to prove RNAi

BioPharma Dive

Sat, 09/30/17 - 10:16 am

Alnylam’s rare disease drug shines in trial, paving way for a brand-new class of medicines

Stat

Wed, 09/20/17 - 09:27 am

familial amyloid polyneuropathy

Alnylam review turns up no clear answers on revusiran deaths

BioPharma Dive

Thu, 08/10/17 - 06:53 pm

EuroBiotech Report: Brexit, BioNTech success, GlaxoSmithKline inks AI deal, Silence takes Alnylam to court and Shire makes cuts

Fierce Biotech

Thu, 07/6/17 - 05:58 pm

artificial intelligence

Silence Therapeutics

Alnylam lines up Phase 3 for another RNAi drug

BioPharma Dive

Tue, 06/27/17 - 10:33 am

acute hepatic porphyrias

Alnylam shares crater after deaths force investigators to scrap PhIII RNAi drug

Endpoints

Wed, 10/5/16 - 05:19 pm

clinical trials

Could Alnylam Pharmaceuticals Change Medicine as We Know It?

Motley Fool

Tue, 05/31/16 - 09:16 am

Sanofi steps deeper into RNAi work, opts in on Alnylam hemophilia drug

Fierce Biotech

Fri, 10/2/15 - 04:53 pm

Tekmira's Ebola drug comes up short in Phase II

Fierce Biotech

Fri, 06/19/15 - 10:53 am

Alnylam's star RNAi drug keeps the pace on the way to Phase III

Fierce Biotech

Tue, 04/21/15 - 12:20 pm

Silence Therapeutics raises $58 million to advance R&D

BioPharma Dive

Thu, 04/9/15 - 03:12 pm

Silence Therapeutics

Novartis sells its RNAi cast-offs from Alnylam in $35M fire sale to Arrowhead

Fierce Biotech

Thu, 03/5/15 - 08:21 am

Arrowhead Research

Alnylam reports results from Phase 2 revusiran trial

Seeking Alpha

Fri, 11/14/14 - 09:54 am

TTR cardiac amyloidosis

Study Suggests RNAi Drug Has Potential in Ebola Treatment

WSJ Pharmalot

Fri, 08/22/14 - 12:11 pm

Tekmira Pharmaceuticals

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

24/7 Wall St

Mon, 07/28/14 - 12:26 pm

Arrowhead Research

Gilead Sciences

Intercept Pharmaceuticals

Vertex Pharmaceuticals

Is This the Crown Jewel of the ISIS Pipeline?

Motley Fool

Tue, 07/8/14 - 04:50 pm

Isis Pharmaceuticals

Alnylam Strikes Back: Comments From CEO John Maraganore

Forbes

Wed, 04/23/14 - 10:19 am

John Maraganore

Pages